Phase 1/2 study of carfilzomib plus melphalan and prednisone in patients aged over 65 years with newly diagnosed multiple myeloma.
暂无分享,去创建一个
J. Mary | P. Moreau | H. Avet-Loiseau | X. Leleu | L. Planche | C. Touzeau | T. Facon | M. Attal | M. Roussel | C. Chaleteix | M. Tiab | C. Hulin | D. Caillot | L. Benboubker | June Fortin | A. Chiffoleau | B. Kolb